Affiliate Scientist ICES UofT Chronic Disease & Pharmacotherapy Research Program
Wendy Ungar is a senior scientist in child health evaluative sciences at The Hospital for Sick Children (SickKids), an associate professor at the University of Toronto's Institute of Health Policy, Management and Evaluation, and an affiliate scientist at ICES. She is the program director for the International Master's in Health Technology Assessment and Management at the University of Toronto. She has held a Canadian Institutes of Health Research New Investigator Career Award. Her book, Economic Evaluation in Child Health, was published by Oxford University Press in 2010. Dr. Ungar leads a program of research in the application of health economic methods to the paediatric population and also investigates the relationship between policies governing access to prescription medicines and health outcomes in children. In 2007, Dr. Ungar started TASK (Technology Assessment at SickKids), a research unit focusing on technology assessment of pediatric health interventions. In collaboration with clinician scientists at SickKids, Dr. Ungar and TASK have completed several studies across a broad range of clinical areas. Dr. Ungar and her team also maintain the PEDE database, a popular online HTA tool that allows users to search for pediatric economic evaluations published on any topic and utility weights for pediatric health states.
- PhD, Health Policy, Management and Evaluation, University of Toronto
- MSc, Pharmacology and Therapeutics, McGill University
- BA, Biology, Brandeis University
- Health economics
- Health technology assessment
- Pediatric health
- Access to health care
- Health services research
- Canada Research Chair in Economic Evaluation and Technology Assessment in Child Health
- Senior Scientist, Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute
- Professor, Institute of Health Policy, Management and Evaluation, University of Toronto
- Director, Technology Assessment at Sick Kids (TASK)
Awards & Recognition
Relationship of asthma management, socioeconomic status, and medication insurance characteristics to exacerbation frequency in children with asthma
Ungar WJ, Paterson JM, Gomes T, Bikangaga P, Gold M, To T, Kozyrskyj AL. Ann Allergy Asthma Immunol. 2011; 106(1):17-23. Epub 2010 Nov 20.
International differences in asthma guidelines for children
Cope SF, Ungar WJ, Glazier RH. Int Arch Allergy Immunol. 2009; 148(4):265-78. Epub 2008 Nov 11.
Socioeconomic factors and asthma control in children
Cope SF, Ungar WJ, Glazier RH. Pediatr Pulmonol. 2008; 43(8):745-52.
Improving drug benefits for children with asthma: results of a multi-stakeholder workshop to build a research agenda
Ungar WJ, Paterson M, Cope S, Kozyrskyj A. Healthc Policy. 2008; 3(4):66-77.
Effect of cost-sharing on use of asthma medication in children
Ungar W, Kozyrskyj A, Paterson M, Ahmad F. Arch Pediatr Adolesc Med. 2008; 162(2):104-10.
Get in touch with
"*" indicates required fields